Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Molecular Endocrinology (Baltimore, Md.)|March 16, 2007
A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulatorKevin P Madauss, Eugene T Grygielko, Su-Jun Deng, et al.
British Journal of Cancer|August 10, 2007
Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survivalL Pitkin, S Luangdilok, C Corbishley, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2009
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonistsScott K Thompson, David G Washburn, James S Frazee, et al.
Mucosal Immunology|April 29, 2011
Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trialA Gori, G Rizzardini, B Van't Land, et al.
European Stroke Journal|April 23, 2019
Clinical risk scores for predicting stroke-associated pneumonia: A systematic reviewAmit K Kishore, Andy Vail, Benjamin D Bray, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2009
Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonistsMarlys Hammond, Jaclyn R Patterson, Sharada Manns, et al.
Lancet (London, England)|September 15, 1999
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialL A Guay, P Musoke, T Fleming, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonistsDavid G Washburn, Tram H Hoang, James S Frazee, et al.
Biochimica Et Biophysica Acta|February 12, 2014
Single-molecule in vivo imaging of bacterial respiratory complexes indicates delocalized oxidative phosphorylationIsabel Llorente-Garcia, Tchern Lenn, Heiko Erhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Pageof 22